GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹2,545 Cr | ₹2,447 Cr | ₹2,516 Cr | ₹2,327 Cr | ₹2,567 Cr |
What is the latest Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹2,545 Cr |
Mar2023 | ₹2,447 Cr |
Mar2022 | ₹2,516 Cr |
Mar2021 | ₹2,327 Cr |
Mar2020 | ₹2,567 Cr |
How is Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹2,545 Cr | 3.99 | |
Mar2023 | ₹2,447 Cr | -2.73 | |
Mar2022 | ₹2,516 Cr | 8.11 | |
Mar2021 | ₹2,327 Cr | -9.34 | |
Mar2020 | ₹2,567 Cr | - |
Compare Total Expenditure of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹46,098.0 Cr | -4.2% | 5.6% | 35.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,588.0 Cr | -7.3% | 1.1% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,711.0 Cr | -3.5% | 12.9% | 53.4% | Stock Analytics | |
CIPLA | ₹122,115.0 Cr | 0.1% | 9.2% | 6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,589.0 Cr | -1% | 0.2% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,746.6 Cr | 3.1% | 9.8% | -7.6% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -4.2% |
5.6% |
35.4% |
SENSEX | 2% |
9.4% |
11.6% |
You may also like the below Video Courses